Alitretinoin for Severe Chronic Hand Eczema: A NICE Single Technology Appraisal

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.5, 2010-05, pp. : 351-362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alitretinoin: In Severe Chronic Hand Eczema

By Garnock-Jones Karly P. Perry Caroline M.

Drugs, Vol. 69, Iss. 12, 2009-08 ,pp. : 1625-1634

Adis International

Access to resources Recommend Favorite

Alitretinoin: a guide to its use in severe chronic hand eczema

Drugs & Therapy Perspectives, Vol. 26, Iss. 4, 2010-04 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Alitretinoin [Toctino; Basilea Pharmaceutica] has been accepted as a treatment for severe chronic hand eczema in Scotland's NHS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 574, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Use of Longitudinal Dose–Response Modeling to Support the Efficacy and Tolerability of Alitretinoin in Severe Refractory Chronic Hand Eczema (CHE)

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 4, 2015-04 ,pp. : 255-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6-11 Years: A NICE Single Technology Appraisal

By Burch Jane

PharmacoEconomics, Vol. 30, Iss. 11, 2012-11 ,pp. : 991-1004

Adis International

Access to resources Recommend Favorite